Anadolu Medical Center
Pancreatic neuroendocrine tumors treatment cost in Turkey typically ranges from AUD $6,701 to AUD $13,541 for non-invasive options like CyberKnife, while more complex interventions like NanoKnife run from AUD $13,262 to AUD $21,638. Total expenses depend on the tumor stage and the specific surgical approach required. Australian patients generally save between 40% and 60% compared to local private healthcare prices. Istanbul and Antalya are the primary hubs for these specialised procedures.
Typical Pancreatic Neuroendocrine Tumors Treatment Costs in Turkey
Bookimed Expert Insight: Patients requiring advanced nuclear medicine benefit from the high-volume expertise at Medipol Mega University Hospital. This centre handles over 1,000 patients daily and provides rarer targeted options like Actinium-225. For complex surgical cases, Anadolu Medical Center offers treatment following U.S. protocols. This is possible through its official affiliation with Johns Hopkins Hospital. Specialist doctors like Professor Yesim Yildirim bring over 20 years of oncology experience to these multidisciplinary teams.
| Turkey | Thailand | South Korea | |
| NanoKnife | from AUD $13,262 | from AUD $15,356 | from AUD $24,430 |
| CyberKnife | from AUD $6,631 | from AUD $41,880 | from AUD $16,054 |
| Enucleation of tumor on pancreas | from AUD $13,960 | - | - |
| Actinium-225 Therapy | from AUD $32,045 | from AUD $34,900 | - |
Professor Bulent Karagoz is a leading medical oncologist at Anadolu Medical Center, specialising in tumor immunology and targeted therapies for complex cancers.
Associate Professor Mustafa Solak has managed over 1,100 cancer treatments and trained at the MD Anderson Cancer Center – one of the world's highest-ranked oncology hospitals.
Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.
Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.
Turkish oncology centres provide treatments for pancreatic neuroendocrine tumours (PanNETs) including complex surgery, Peptide Receptor Radionuclide Therapy (PRRT), and targeted alpha therapy. Specialists at JCI-accredited facilities like Anadolu Medical Center use Lutetium-177 and Actinium-225 to target somatostatin receptors with high precision.
Bookimed Expert Insight: Turkish centres like Anadolu Medical Center maintain formal affiliations with Johns Hopkins Medicine. This means patients receive treatment protocols identical to top American hospitals. Our data shows these facilities often bundle diagnostic DOTA PET scans and MAG-3 renal scintigraphy into therapy packages. This provides a more comprehensive staging process than standard chemotherapy-only clinics.
Patient Consensus: Patients note that Turkish specialists often combine immunotherapy and chemotherapy to reduce tumour size significantly before surgery. Many emphasise that having a dedicated Russian or English-speaking curator makes navigating complex nuclear medicine procedures much easier.
Peptide Receptor Radionuclide Therapy (PRRT) is accessible in Turkey for advanced pancreatic neuroendocrine tumours. Major JCI-accredited oncology centres provide targeted Lutetium-177 and Actinium-225 therapies. Eligibility requires positive somatostatin receptor expression confirmed by Ga-68 DOTATATE PET scans. Nuclear medicine specialists manage the multidisciplinary treatment cycles.
Bookimed Expert Insight: Turkish nuclear medicine departments are uniquely positioned by offering both Lutetium-177 and Actinium-225 therapies. While Lutetium-177 is the standard PRRT, Actinium-225 is a more intensive alpha therapy used when tumours stop responding. Expert specialists provide these protocols at Anadolu Medical Center. Prof. Dr Kezban Berberoglu, for example, trained at Johns Hopkins.
Patient Consensus: Patients in Turkey highlight the high quality of nuclear medicine specialists. They also appreciate the convenience of free airport transfers. Many note the manageability of treatment cycles. They also mention the helpfulness of Russian and English-speaking curators during the radioactive precaution periods.
Leading Turkish hospitals for neuroendocrine and pancreatic cancers include Anadolu Medical Center, Memorial Şişli, and Hisar Intercontinental. These JCI-accredited facilities specialise in Actinium-225 therapy, robotic Whipple procedures, and CyberKnife radiosurgery. Specialists there follow international ESMO guidelines to treat complex gastrointestinal malignancies.
Bookimed Expert Insight: Anadolu Medical Center stands out for Australian patients due to its formal affiliation with Johns Hopkins Medicine. This partnership keeps clinical protocols aligned with American standards. Data shows their oncology packages, such as Actinium-225 therapy for approximately A$31,700, include comprehensive DOTA PET scans and renal scintigraphy. These scans help monitor kidney safety during intensive treatment.
Patient Consensus: Patients in Turkey value the seamless logistics, noting that Medipol Mega and Hisar provide free interpreters and airport transfers. They appreciate the modern guest houses and clear communication with nuclear medicine professors during complex Lutetium cycles.
Pancreatic neuroendocrine tumour treatment in Turkey follows a structured process. It involves multidisciplinary review, advanced imaging, and specialised therapies. Patients undergo diagnostic staging via DOTA PET scans. Afterwards, they start surgery or nuclear treatments like Actinium-225. Recovery ranges from 7 days for systemic therapies. For complex surgical resections, it takes up to 3 months.
Bookimed Expert Insight: Data indicates a significant expertise gap in complex oncology cases. Professors like Dr Kezban Berberoglu and Dr Sezer Saglam lead multidisciplinary boards. They practise at Anadolu and Florence Nightingale. These specialists often manage over 400 cases annually. This depth of experience directly improves outcomes for rare neuroendocrine malignancies.
Patient Consensus: Patients value the seamless coordination. This includes airport ramp pickups, free hospital transfers, and dedicated interpreters. Many note that Turkish centres like Medipol Mega provide affordable 5-star accommodation nearby. Long-term recovery and follow-up scans become much more manageable. This is especially helpful for those travelling from Australia.